Quick Answer
Elanco Animal Health Inc reported Cash and Equivalents of $545.00 million for fiscal year 2025.
Elanco Animal Health Inc Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $545.00M | +16.5% |
| 2024 | $468.00M | +33.0% |
| 2023 | $352.00M | +2.0% |
| 2022 | $345.00M | -45.9% |
| 2021 | $638.00M | +28.9% |
| 2020 | $495.00M | +48.2% |
| 2019 | $334.00M | -29.7% |
| 2018 | $474.80M | +46.8% |
| 2017 | $323.40M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $505.00M | +3.1% | -6.3% |
| June 30, 2025 | $539.00M | +29.6% | +10.7% |
| March 31, 2025 | $487.00M | +41.2% | +4.1% |
| December 31, 2024 | $468.00M | +33.0% | -4.5% |
| September 30, 2024 | $490.00M | +32.8% | +17.8% |
| June 30, 2024 | $416.00M | +13.4% | +20.6% |
| March 31, 2024 | $345.00M | +8.5% | -2.0% |
| December 31, 2023 | $352.00M | +2.0% | -4.6% |
- Elanco Animal Health Inc showed an increase of +16.5% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2017–2025 period, Elanco Animal Health Inc’s cash and equivalents has grown by 68.5% (from $323.40 million to $545.00 million).
- The most recent figure is from Elanco Animal Health Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: